HEADER CELL CYCLE 11-DEC-20 7B7S TITLE CDK2/CYCLIN A2 IN COMPLEX WITH 3H-PYRAZOLO[4,3-F]QUINOLINE-BASED TITLE 2 DERIVATIVE HSD1368 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIN-DEPENDENT KINASE 2; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: CELL DIVISION PROTEIN KINASE 2,P33 PROTEIN KINASE; COMPND 5 EC: 2.7.11.22; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CYCLIN-A2; COMPND 9 CHAIN: B, D; COMPND 10 SYNONYM: CYCLIN-A,CYCLIN A; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CDK2, CDKN2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: CCNA2, CCN1, CCNA; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CYCLIN-DEPENDENT KINASE, FLT3, ACUTE MYELOID LEUKEMIA, INHIBITION, KEYWDS 2 CELL CYCLE EXPDTA X-RAY DIFFRACTION AUTHOR S.DJUKIC,J.SKERLOVA,P.REZACOVA REVDAT 4 06-NOV-24 7B7S 1 REMARK REVDAT 3 31-JAN-24 7B7S 1 REMARK REVDAT 2 25-AUG-21 7B7S 1 JRNL REVDAT 1 04-AUG-21 7B7S 0 JRNL AUTH N.DAYAL,E.REZNICKOVA,D.E.HERNANDEZ,M.PERINA, JRNL AUTH 2 S.TORREGROSA-ALLEN,B.D.ELZEY,J.SKERLOVA,H.AJANI,S.DJUKIC, JRNL AUTH 3 V.VOJACKOVA,M.LEPSIK,P.REZACOVA,V.KRYSTOF,R.JORDA,H.O.SINTIM JRNL TITL 3 H -PYRAZOLO[4,3- F ]QUINOLINE-BASED KINASE INHIBITORS JRNL TITL 2 INHIBIT THE PROLIFERATION OF ACUTE MYELOID LEUKEMIA CELLS IN JRNL TITL 3 VIVO. JRNL REF J.MED.CHEM. V. 64 10981 2021 JRNL REFN ISSN 0022-2623 JRNL PMID 34288692 JRNL DOI 10.1021/ACS.JMEDCHEM.1C00330 REMARK 2 REMARK 2 RESOLUTION. 2.54 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.54 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.10 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 84.1 REMARK 3 NUMBER OF REFLECTIONS : 41850 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.248 REMARK 3 R VALUE (WORKING SET) : 0.246 REMARK 3 FREE R VALUE : 0.291 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 2129 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.54 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.61 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2431 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 65.88 REMARK 3 BIN R VALUE (WORKING SET) : 0.3300 REMARK 3 BIN FREE R VALUE SET COUNT : 120 REMARK 3 BIN FREE R VALUE : 0.3760 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8729 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 73 REMARK 3 SOLVENT ATOMS : 77 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.41 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.52 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.00000 REMARK 3 B22 (A**2) : -3.52000 REMARK 3 B33 (A**2) : -3.30000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 2.37000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.801 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.367 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.895 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.853 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 9025 ; 0.011 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 8722 ; 0.034 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 12248 ; 1.623 ; 1.653 REMARK 3 BOND ANGLES OTHERS (DEGREES): 20121 ; 2.246 ; 1.581 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1074 ; 6.606 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 429 ;37.587 ;22.494 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1589 ;16.232 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 44 ;17.018 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1154 ; 0.070 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 9863 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1979 ; 0.009 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NCS TYPE: LOCAL REMARK 3 NUMBER OF DIFFERENT NCS PAIRS : 2 REMARK 3 GROUP CHAIN1 RANGE CHAIN2 RANGE COUNT RMS WEIGHT REMARK 3 1 A 1 293 C 1 293 8920 0.100 0.050 REMARK 3 2 B 177 430 D 177 430 8262 0.080 0.050 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7B7S COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-DEC-20. REMARK 100 THE DEPOSITION ID IS D_1292112785. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-JUN-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 43971 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.540 REMARK 200 RESOLUTION RANGE LOW (A) : 47.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 84.0 REMARK 200 DATA REDUNDANCY : 5.502 REMARK 200 R MERGE (I) : 0.30900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.3500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.54 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.70 REMARK 200 COMPLETENESS FOR SHELL (%) : 69.2 REMARK 200 DATA REDUNDANCY IN SHELL : 4.76 REMARK 200 R MERGE FOR SHELL (I) : 1.42900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 6GVA REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 61.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.19 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 80% MORPHEUS CONDITION 35 CONTAINING: REMARK 280 10% W/V PEG 4,000, 20% V/V GLYCEROL, 0.03 M NANO3, 0.03 M REMARK 280 NA2HPO4, 0.03 M (NH4)2SO4, 0.1 M TRIS/BICINE PH 8.5 AND 20% OF REMARK 280 JCSG+ CONDITION 59 CONTAINING: 14.4 % W/V PEG 8,000, 20% V/V REMARK 280 GLYCEROL, 0.16 M CALCIUM ACETATE, 0.08 M SODIUM CACODYLATE PH REMARK 280 6.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 82.35000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2980 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24020 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3510 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23790 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -26.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 0 REMARK 465 TYR A 15 REMARK 465 GLY A 16 REMARK 465 THR A 39 REMARK 465 GLU A 40 REMARK 465 THR A 72 REMARK 465 GLU A 73 REMARK 465 PRO A 294 REMARK 465 HIS A 295 REMARK 465 LEU A 296 REMARK 465 ARG A 297 REMARK 465 LEU A 298 REMARK 465 VAL B 175 REMARK 465 PRO B 176 REMARK 465 ASN B 431 REMARK 465 LEU B 432 REMARK 465 SER C 0 REMARK 465 TYR C 15 REMARK 465 THR C 39 REMARK 465 GLU C 40 REMARK 465 THR C 72 REMARK 465 GLU C 73 REMARK 465 PRO C 294 REMARK 465 HIS C 295 REMARK 465 LEU C 296 REMARK 465 ARG C 297 REMARK 465 LEU C 298 REMARK 465 VAL D 175 REMARK 465 PRO D 176 REMARK 465 GLN D 323 REMARK 465 PRO D 324 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 58 71.50 -119.99 REMARK 500 ASP A 127 30.55 -162.59 REMARK 500 ASN A 136 -168.41 -105.02 REMARK 500 ASP A 145 85.39 55.58 REMARK 500 TPO A 160 133.17 -39.88 REMARK 500 VAL A 164 139.04 74.12 REMARK 500 SER A 181 -134.63 -149.62 REMARK 500 ARG A 199 29.90 49.77 REMARK 500 PRO A 292 -171.92 -67.30 REMARK 500 LYS B 226 45.70 33.99 REMARK 500 SER B 245 34.55 -154.94 REMARK 500 PHE B 304 16.77 52.99 REMARK 500 TRP B 372 106.49 -33.60 REMARK 500 LEU C 37 47.97 -97.42 REMARK 500 ASP C 127 24.66 -163.73 REMARK 500 ASP C 145 80.56 63.39 REMARK 500 VAL C 164 137.67 75.44 REMARK 500 SER C 181 -139.72 -157.18 REMARK 500 PRO C 292 -169.84 -68.75 REMARK 500 LYS D 226 51.07 32.47 REMARK 500 SER D 245 16.87 -154.82 REMARK 500 PHE D 304 15.80 54.39 REMARK 500 LYS D 349 4.00 -67.96 REMARK 500 GLN D 407 -7.18 -140.83 REMARK 500 REMARK 500 REMARK: NULL DBREF 7B7S A 1 298 UNP P24941 CDK2_HUMAN 1 298 DBREF 7B7S B 175 432 UNP P20248 CCNA2_HUMAN 175 432 DBREF 7B7S C 1 298 UNP P24941 CDK2_HUMAN 1 298 DBREF 7B7S D 175 432 UNP P20248 CCNA2_HUMAN 175 432 SEQADV 7B7S SER A 0 UNP P24941 EXPRESSION TAG SEQADV 7B7S SER C 0 UNP P24941 EXPRESSION TAG SEQRES 1 A 299 SER MET GLU ASN PHE GLN LYS VAL GLU LYS ILE GLY GLU SEQRES 2 A 299 GLY THR TYR GLY VAL VAL TYR LYS ALA ARG ASN LYS LEU SEQRES 3 A 299 THR GLY GLU VAL VAL ALA LEU LYS LYS ILE ARG LEU ASP SEQRES 4 A 299 THR GLU THR GLU GLY VAL PRO SER THR ALA ILE ARG GLU SEQRES 5 A 299 ILE SER LEU LEU LYS GLU LEU ASN HIS PRO ASN ILE VAL SEQRES 6 A 299 LYS LEU LEU ASP VAL ILE HIS THR GLU ASN LYS LEU TYR SEQRES 7 A 299 LEU VAL PHE GLU PHE LEU HIS GLN ASP LEU LYS LYS PHE SEQRES 8 A 299 MET ASP ALA SER ALA LEU THR GLY ILE PRO LEU PRO LEU SEQRES 9 A 299 ILE LYS SER TYR LEU PHE GLN LEU LEU GLN GLY LEU ALA SEQRES 10 A 299 PHE CYS HIS SER HIS ARG VAL LEU HIS ARG ASP LEU LYS SEQRES 11 A 299 PRO GLN ASN LEU LEU ILE ASN THR GLU GLY ALA ILE LYS SEQRES 12 A 299 LEU ALA ASP PHE GLY LEU ALA ARG ALA PHE GLY VAL PRO SEQRES 13 A 299 VAL ARG THR TYR TPO HIS GLU VAL VAL THR LEU TRP TYR SEQRES 14 A 299 ARG ALA PRO GLU ILE LEU LEU GLY CYS LYS TYR TYR SER SEQRES 15 A 299 THR ALA VAL ASP ILE TRP SER LEU GLY CYS ILE PHE ALA SEQRES 16 A 299 GLU MET VAL THR ARG ARG ALA LEU PHE PRO GLY ASP SER SEQRES 17 A 299 GLU ILE ASP GLN LEU PHE ARG ILE PHE ARG THR LEU GLY SEQRES 18 A 299 THR PRO ASP GLU VAL VAL TRP PRO GLY VAL THR SER MET SEQRES 19 A 299 PRO ASP TYR LYS PRO SER PHE PRO LYS TRP ALA ARG GLN SEQRES 20 A 299 ASP PHE SER LYS VAL VAL PRO PRO LEU ASP GLU ASP GLY SEQRES 21 A 299 ARG SER LEU LEU SER GLN MET LEU HIS TYR ASP PRO ASN SEQRES 22 A 299 LYS ARG ILE SER ALA LYS ALA ALA LEU ALA HIS PRO PHE SEQRES 23 A 299 PHE GLN ASP VAL THR LYS PRO VAL PRO HIS LEU ARG LEU SEQRES 1 B 258 VAL PRO ASP TYR HIS GLU ASP ILE HIS THR TYR LEU ARG SEQRES 2 B 258 GLU MET GLU VAL LYS CYS LYS PRO LYS VAL GLY TYR MET SEQRES 3 B 258 LYS LYS GLN PRO ASP ILE THR ASN SER MET ARG ALA ILE SEQRES 4 B 258 LEU VAL ASP TRP LEU VAL GLU VAL GLY GLU GLU TYR LYS SEQRES 5 B 258 LEU GLN ASN GLU THR LEU HIS LEU ALA VAL ASN TYR ILE SEQRES 6 B 258 ASP ARG PHE LEU SER SER MET SER VAL LEU ARG GLY LYS SEQRES 7 B 258 LEU GLN LEU VAL GLY THR ALA ALA MET LEU LEU ALA SER SEQRES 8 B 258 LYS PHE GLU GLU ILE TYR PRO PRO GLU VAL ALA GLU PHE SEQRES 9 B 258 VAL TYR ILE THR ASP ASP THR TYR THR LYS LYS GLN VAL SEQRES 10 B 258 LEU ARG MET GLU HIS LEU VAL LEU LYS VAL LEU THR PHE SEQRES 11 B 258 ASP LEU ALA ALA PRO THR VAL ASN GLN PHE LEU THR GLN SEQRES 12 B 258 TYR PHE LEU HIS GLN GLN PRO ALA ASN CYS LYS VAL GLU SEQRES 13 B 258 SER LEU ALA MET PHE LEU GLY GLU LEU SER LEU ILE ASP SEQRES 14 B 258 ALA ASP PRO TYR LEU LYS TYR LEU PRO SER VAL ILE ALA SEQRES 15 B 258 GLY ALA ALA PHE HIS LEU ALA LEU TYR THR VAL THR GLY SEQRES 16 B 258 GLN SER TRP PRO GLU SER LEU ILE ARG LYS THR GLY TYR SEQRES 17 B 258 THR LEU GLU SER LEU LYS PRO CYS LEU MET ASP LEU HIS SEQRES 18 B 258 GLN THR TYR LEU LYS ALA PRO GLN HIS ALA GLN GLN SER SEQRES 19 B 258 ILE ARG GLU LYS TYR LYS ASN SER LYS TYR HIS GLY VAL SEQRES 20 B 258 SER LEU LEU ASN PRO PRO GLU THR LEU ASN LEU SEQRES 1 C 299 SER MET GLU ASN PHE GLN LYS VAL GLU LYS ILE GLY GLU SEQRES 2 C 299 GLY THR TYR GLY VAL VAL TYR LYS ALA ARG ASN LYS LEU SEQRES 3 C 299 THR GLY GLU VAL VAL ALA LEU LYS LYS ILE ARG LEU ASP SEQRES 4 C 299 THR GLU THR GLU GLY VAL PRO SER THR ALA ILE ARG GLU SEQRES 5 C 299 ILE SER LEU LEU LYS GLU LEU ASN HIS PRO ASN ILE VAL SEQRES 6 C 299 LYS LEU LEU ASP VAL ILE HIS THR GLU ASN LYS LEU TYR SEQRES 7 C 299 LEU VAL PHE GLU PHE LEU HIS GLN ASP LEU LYS LYS PHE SEQRES 8 C 299 MET ASP ALA SER ALA LEU THR GLY ILE PRO LEU PRO LEU SEQRES 9 C 299 ILE LYS SER TYR LEU PHE GLN LEU LEU GLN GLY LEU ALA SEQRES 10 C 299 PHE CYS HIS SER HIS ARG VAL LEU HIS ARG ASP LEU LYS SEQRES 11 C 299 PRO GLN ASN LEU LEU ILE ASN THR GLU GLY ALA ILE LYS SEQRES 12 C 299 LEU ALA ASP PHE GLY LEU ALA ARG ALA PHE GLY VAL PRO SEQRES 13 C 299 VAL ARG THR TYR TPO HIS GLU VAL VAL THR LEU TRP TYR SEQRES 14 C 299 ARG ALA PRO GLU ILE LEU LEU GLY CYS LYS TYR TYR SER SEQRES 15 C 299 THR ALA VAL ASP ILE TRP SER LEU GLY CYS ILE PHE ALA SEQRES 16 C 299 GLU MET VAL THR ARG ARG ALA LEU PHE PRO GLY ASP SER SEQRES 17 C 299 GLU ILE ASP GLN LEU PHE ARG ILE PHE ARG THR LEU GLY SEQRES 18 C 299 THR PRO ASP GLU VAL VAL TRP PRO GLY VAL THR SER MET SEQRES 19 C 299 PRO ASP TYR LYS PRO SER PHE PRO LYS TRP ALA ARG GLN SEQRES 20 C 299 ASP PHE SER LYS VAL VAL PRO PRO LEU ASP GLU ASP GLY SEQRES 21 C 299 ARG SER LEU LEU SER GLN MET LEU HIS TYR ASP PRO ASN SEQRES 22 C 299 LYS ARG ILE SER ALA LYS ALA ALA LEU ALA HIS PRO PHE SEQRES 23 C 299 PHE GLN ASP VAL THR LYS PRO VAL PRO HIS LEU ARG LEU SEQRES 1 D 258 VAL PRO ASP TYR HIS GLU ASP ILE HIS THR TYR LEU ARG SEQRES 2 D 258 GLU MET GLU VAL LYS CYS LYS PRO LYS VAL GLY TYR MET SEQRES 3 D 258 LYS LYS GLN PRO ASP ILE THR ASN SER MET ARG ALA ILE SEQRES 4 D 258 LEU VAL ASP TRP LEU VAL GLU VAL GLY GLU GLU TYR LYS SEQRES 5 D 258 LEU GLN ASN GLU THR LEU HIS LEU ALA VAL ASN TYR ILE SEQRES 6 D 258 ASP ARG PHE LEU SER SER MET SER VAL LEU ARG GLY LYS SEQRES 7 D 258 LEU GLN LEU VAL GLY THR ALA ALA MET LEU LEU ALA SER SEQRES 8 D 258 LYS PHE GLU GLU ILE TYR PRO PRO GLU VAL ALA GLU PHE SEQRES 9 D 258 VAL TYR ILE THR ASP ASP THR TYR THR LYS LYS GLN VAL SEQRES 10 D 258 LEU ARG MET GLU HIS LEU VAL LEU LYS VAL LEU THR PHE SEQRES 11 D 258 ASP LEU ALA ALA PRO THR VAL ASN GLN PHE LEU THR GLN SEQRES 12 D 258 TYR PHE LEU HIS GLN GLN PRO ALA ASN CYS LYS VAL GLU SEQRES 13 D 258 SER LEU ALA MET PHE LEU GLY GLU LEU SER LEU ILE ASP SEQRES 14 D 258 ALA ASP PRO TYR LEU LYS TYR LEU PRO SER VAL ILE ALA SEQRES 15 D 258 GLY ALA ALA PHE HIS LEU ALA LEU TYR THR VAL THR GLY SEQRES 16 D 258 GLN SER TRP PRO GLU SER LEU ILE ARG LYS THR GLY TYR SEQRES 17 D 258 THR LEU GLU SER LEU LYS PRO CYS LEU MET ASP LEU HIS SEQRES 18 D 258 GLN THR TYR LEU LYS ALA PRO GLN HIS ALA GLN GLN SER SEQRES 19 D 258 ILE ARG GLU LYS TYR LYS ASN SER LYS TYR HIS GLY VAL SEQRES 20 D 258 SER LEU LEU ASN PRO PRO GLU THR LEU ASN LEU MODRES 7B7S TPO A 160 THR MODIFIED RESIDUE MODRES 7B7S TPO C 160 THR MODIFIED RESIDUE HET TPO A 160 11 HET TPO C 160 11 HET T1T A 301 27 HET NO3 A 302 4 HET SO4 A 303 5 HET T1T C 301 27 HET NO3 C 302 4 HET SGM D 601 6 HETNAM TPO PHOSPHOTHREONINE HETNAM T1T 7-(3-(TRIFLUOROMETHYL)-1H-PYRAZOL-4YL)-3,8,10,11- HETNAM 2 T1T TETRAHYDROPYRAZOLO[4,3-F]THIOPYRANO[3,4-C]QUINOLINE 9- HETNAM 3 T1T OXIDE HETNAM NO3 NITRATE ION HETNAM SO4 SULFATE ION HETNAM SGM MONOTHIOGLYCEROL HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 5 T1T 2(C17 H12 F3 N5 O S) FORMUL 6 NO3 2(N O3 1-) FORMUL 7 SO4 O4 S 2- FORMUL 10 SGM C3 H8 O2 S FORMUL 11 HOH *77(H2 O) HELIX 1 AA1 PRO A 45 LYS A 56 1 12 HELIX 2 AA2 LEU A 87 ASP A 92 1 6 HELIX 3 AA3 PRO A 100 HIS A 121 1 22 HELIX 4 AA4 LYS A 129 GLN A 131 5 3 HELIX 5 AA5 THR A 165 ARG A 169 5 5 HELIX 6 AA6 ALA A 170 LEU A 175 1 6 HELIX 7 AA7 THR A 182 THR A 198 1 17 HELIX 8 AA8 SER A 207 GLY A 220 1 14 HELIX 9 AA9 GLY A 229 MET A 233 5 5 HELIX 10 AB1 ASP A 247 VAL A 252 1 6 HELIX 11 AB2 ASP A 256 LEU A 267 1 12 HELIX 12 AB3 SER A 276 LEU A 281 1 6 HELIX 13 AB4 ALA A 282 GLN A 287 5 6 HELIX 14 AB5 TYR B 178 CYS B 193 1 16 HELIX 15 AB6 GLY B 198 GLN B 203 1 6 HELIX 16 AB7 THR B 207 TYR B 225 1 19 HELIX 17 AB8 GLN B 228 SER B 244 1 17 HELIX 18 AB9 LEU B 249 GLY B 251 5 3 HELIX 19 AC1 LYS B 252 GLU B 269 1 18 HELIX 20 AC2 GLU B 274 ILE B 281 1 8 HELIX 21 AC3 THR B 287 THR B 303 1 17 HELIX 22 AC4 THR B 310 PHE B 319 1 10 HELIX 23 AC5 LEU B 320 GLN B 322 5 3 HELIX 24 AC6 ASN B 326 ASP B 343 1 18 HELIX 25 AC7 ASP B 343 LEU B 348 1 6 HELIX 26 AC8 LEU B 351 THR B 368 1 18 HELIX 27 AC9 PRO B 373 GLY B 381 1 9 HELIX 28 AD1 THR B 383 LYS B 400 1 18 HELIX 29 AD2 GLN B 407 TYR B 413 1 7 HELIX 30 AD3 GLY B 420 LEU B 424 5 5 HELIX 31 AD4 PRO C 45 LYS C 56 1 12 HELIX 32 AD5 LEU C 87 ASP C 92 1 6 HELIX 33 AD6 PRO C 100 HIS C 121 1 22 HELIX 34 AD7 LYS C 129 GLN C 131 5 3 HELIX 35 AD8 THR C 165 ARG C 169 5 5 HELIX 36 AD9 ALA C 170 LEU C 175 1 6 HELIX 37 AE1 THR C 182 THR C 198 1 17 HELIX 38 AE2 SER C 207 GLY C 220 1 14 HELIX 39 AE3 GLY C 229 MET C 233 5 5 HELIX 40 AE4 ASP C 247 VAL C 252 1 6 HELIX 41 AE5 ASP C 256 LEU C 267 1 12 HELIX 42 AE6 SER C 276 LEU C 281 1 6 HELIX 43 AE7 ALA C 282 GLN C 287 5 6 HELIX 44 AE8 TYR D 178 CYS D 193 1 16 HELIX 45 AE9 GLY D 198 GLN D 203 1 6 HELIX 46 AF1 THR D 207 TYR D 225 1 19 HELIX 47 AF2 GLN D 228 SER D 244 1 17 HELIX 48 AF3 LEU D 249 GLU D 269 1 21 HELIX 49 AF4 GLU D 274 ILE D 281 1 8 HELIX 50 AF5 THR D 287 THR D 303 1 17 HELIX 51 AF6 THR D 310 PHE D 319 1 10 HELIX 52 AF7 LEU D 320 GLN D 322 5 3 HELIX 53 AF8 ASN D 326 ASP D 343 1 18 HELIX 54 AF9 ASP D 343 LEU D 348 1 6 HELIX 55 AG1 LEU D 351 THR D 368 1 18 HELIX 56 AG2 PRO D 373 GLY D 381 1 9 HELIX 57 AG3 THR D 383 LYS D 400 1 18 HELIX 58 AG4 GLN D 407 TYR D 413 1 7 HELIX 59 AG5 LYS D 414 HIS D 419 5 6 HELIX 60 AG6 GLY D 420 LEU D 424 5 5 SHEET 1 AA1 5 PHE A 4 LYS A 9 0 SHEET 2 AA1 5 VAL A 18 ASN A 23 -1 O ARG A 22 N GLN A 5 SHEET 3 AA1 5 VAL A 29 ARG A 36 -1 O VAL A 30 N ALA A 21 SHEET 4 AA1 5 LYS A 75 GLU A 81 -1 O LEU A 76 N ILE A 35 SHEET 5 AA1 5 LEU A 66 ILE A 70 -1 N LEU A 67 O VAL A 79 SHEET 1 AA2 3 GLN A 85 ASP A 86 0 SHEET 2 AA2 3 LEU A 133 ILE A 135 -1 O ILE A 135 N GLN A 85 SHEET 3 AA2 3 ILE A 141 LEU A 143 -1 O LYS A 142 N LEU A 134 SHEET 1 AA3 2 VAL A 123 LEU A 124 0 SHEET 2 AA3 2 ARG A 150 ALA A 151 -1 O ARG A 150 N LEU A 124 SHEET 1 AA4 5 PHE C 4 GLU C 12 0 SHEET 2 AA4 5 VAL C 17 ASN C 23 -1 O ARG C 22 N GLN C 5 SHEET 3 AA4 5 VAL C 29 ARG C 36 -1 O LYS C 34 N VAL C 17 SHEET 4 AA4 5 LYS C 75 GLU C 81 -1 O LEU C 76 N ILE C 35 SHEET 5 AA4 5 LEU C 66 ILE C 70 -1 N LEU C 67 O VAL C 79 SHEET 1 AA5 3 GLN C 85 ASP C 86 0 SHEET 2 AA5 3 LEU C 133 ILE C 135 -1 O ILE C 135 N GLN C 85 SHEET 3 AA5 3 ILE C 141 LEU C 143 -1 O LYS C 142 N LEU C 134 SHEET 1 AA6 2 VAL C 123 LEU C 124 0 SHEET 2 AA6 2 ARG C 150 ALA C 151 -1 O ARG C 150 N LEU C 124 LINK C TYR A 159 N TPO A 160 1555 1555 1.33 LINK C TPO A 160 N HIS A 161 1555 1555 1.35 LINK C TYR C 159 N TPO C 160 1555 1555 1.33 LINK C TPO C 160 N HIS C 161 1555 1555 1.35 CISPEP 1 VAL A 154 PRO A 155 0 -6.30 CISPEP 2 ASP B 345 PRO B 346 0 -0.49 CISPEP 3 VAL C 154 PRO C 155 0 -5.82 CISPEP 4 ASP D 345 PRO D 346 0 -2.33 CRYST1 70.077 164.700 73.411 90.00 106.28 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014270 0.000000 0.004167 0.00000 SCALE2 0.000000 0.006072 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014191 0.00000